Market News

Elevated default risks and higher funding costs have contributed to Upstart's impacted loan originations and lowered FY2026 guidance. See more on UPST...

Telephone and Data Systems, Inc. (NYSE:TDS) announced its Board approved incremental $250 million share repurchase authorization. 

Cantor Fitzgerald analyst Gareth Gacetta maintains Hyperliquid Strategies (NASDAQ:PURR) with a Overweight and raises the price target from $34.3 to...

Telephone and Data (NYSE:TDS) reported quarterly earnings of $0.26 per share which beat the analyst consensus estimate of $0.13 by 100 percent. This i...

Lower diarrhea rates emerge, but toxicity control remains the key test.

Guidance rose as international sales neared a fifth of the business.

Agent Studio launch and a big bank expansion highlight the quarter.

Management reaffirmed its 2028 targets as rising yields test the financing model.

Revenue rose as the company winds down its legacy specialty lending unit.

Acquisitions doubled customers, but integration costs deepened the quarterly loss.

Record nine-month revenue, but lender selectivity and tax changes loom ahead.

Investing.com -- British stocks fell on Friday as a global tech rout over AI investment worries after the U.S. midterms spread to Europe.

An example of a high-quality company in our portfolio that also happens to benefit from an improving PMI is Quaker Houghton.

Occidental Petroleum is set to report Q3 earnings. Analysts expect $1.47 EPS and $6.89B revenue; its 1.99% yield requires $301,921 for $500

Nvidia stock looks undervalued with a 46% upside. Explore NVDA's AI-driven revenue growth, Vera Rubin demand, and its widening competitive moat now.

Vericel Corporation (VCEL) Q3 2026 Earnings Call November 5, 2026 8:30 AM ESTCompany ParticipantsEric Burns - Vice President of Finance & Investor...

EDP, S.A. (EDPFY) Q3 2026 Earnings Call November 6, 2026 3:30 AM ESTCompany ParticipantsMiguel Viana - Head of Investor Relations & SustainabilityMigu...

Cantor Fitzgerald analyst Brett Knoblauch maintains IREN (NASDAQ:IREN) with a Overweight and lowers the price target from $99 to $47.

CVS Health will split into two public companies by 1H 2028, separating its pharmacy and health services businesses. Read why CVS stock is a buy.

https://news.lockheedmartin.com/2026-11-06-Sikorsky-Selected-to-Deliver-the-S-92A-Presidential-Helicopter-to-Republic-of-Korea-Air-Force